Flash Finance

Krishna Institute of Medical Sciences LimitedKIMSCorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹685.60
MCap ₹27,434 Cr · P/E 102.4
Krishna Institute of Medical Sciences Limited — Stock analysis & AI research Krishna Institute of Medical Sciences Limited — Multibagger AI analysis Krishna Institute of Medical Sciences Limited — Seasonality — best & worst months Krishna Institute of Medical Sciences Limited — Technical indicators & charts Krishna Institute of Medical Sciences Limited — Technical setup — score, trend, support & resistance Krishna Institute of Medical Sciences Limited — Live exchange announcements
📋 Small Cap Stocks List 📈 Lowest Technical Score 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹484 Cr
Sales · Jun 2026
+29.5% YoY
₹118 Cr
Operating Profit · Jun 2026
+21.2% YoY
24.4%
OPM % · Jun 2026
-6.5% YoY
₹66 Cr
Net Profit · Jun 2026
+13.1% YoY
₹1.66
EPS · Jun 2026
+12.9% YoY

📝 Krishna Institute of Medical Sciences Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Krishna Institute of Medical Sciences Limited reported revenue of ₹484 crore for the quarter ended June 2026 (Q1 FY27), up 29.5% from ₹373 crore in the same quarter last year, and up 6.1% sequentially over the March 2026 quarter.

Net profit rose 13.1% year-on-year to ₹66 crore, from ₹59 crore. Earnings per share (EPS) came in at ₹1.66.

Operating profit stood at ₹118 crore — an operating margin (OPM) of 24.4%, compared with 26.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Krishna Institute of Medical Sciences Limited posted revenue of ₹1,701 crore, a growth of 23.0% over FY25, with a net profit of ₹260 crore (down 14.0% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,812 crore with a net profit of ₹268 crore.

Valuation snapshot

At the current price of ₹685.60, KIMS has a market capitalisation of ₹27,434 crore and a trailing P/E of about 102.4.

Within the Medical Care Facilities industry, it is the 8th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 32.50%, foreign institutional investors (FIIs) 14.74%, domestic institutional investors (DIIs) 34.43%, public shareholders 18.33% of Krishna Institute of Medical Sciences Limited.

Promoter holding slipped from 34.11% to 32.50% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹27,434 Cr
Current Price ?
₹685.6
P/E ?
102.36above ind
Industry P/E ?
56.40
P/B ?
11.29
P/S ?
15.14
P/FCF ?
-435.45
Enterprise Value ?
₹28,960 Cr
EV/EBITDA ?
59.29
PEG ?
51.18
Earnings Yield ?
1.4%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹1,812 Cr
OPM ?
27.0%
Profit after tax (TTM) ?
₹268 Cr
EPS (TTM) ?
₹6.70
ROCE ?
13.0%
ROE ?
11.0%
ROA ?
6.3%
Growth
Sales — latest qtr ?
₹484 Cr
PAT — latest qtr ?
₹66 Cr
YoY qtr sales growth ?
29.5%
YoY qtr profit growth ?
13.1%
Sales growth (3y) ?
15%
Sales growth (5y) ?
13%
Profit growth (3y) ?
2%
Profit growth (5y) ?
7%
Financial Health
Debt ?
₹1,526 Cr
Debt to Equity ?
0.63
Interest Coverage ?
4.8
Current Ratio ?
N/A
Ownership
Promoter holding ?
32.50%
Change in promoter holding ?
-1.61%
Pledged percentage ?
N/A
Market
Return 3 months ?
-14.6%
Return 6 months ?
0.5%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 284293299316302305327363348346373430442456484 +29.5% +6.1%
Operating Profit 90104929887869411110310998112128130118 +21.2% -9.1%
Other Income 7544445721241212141131 +151.6% +179.1%
Interest 00001245781218222733 +162.4% +21.5%
Depreciation 111112131320141415151820232627 +56.0% +5.0%
Profit Before Tax 86988489786782991021208086988989 +11.4% -0.2%
Net Profit 647563665848617276945964726666 +13.1% +0.8%
EPS 8.069.337.838.277.296.027.581.801.912.341.471.591.811.651.66 +12.9% +0.6%
OPM % 31.7% 35.6% 30.9% 31.1% 29.0% 28.3% 28.6% 30.6% 29.6% 31.4% 26.1% 26.1% 29.0% 28.5% 24.4% -6.5% -14.4%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,384 Cr ₹1,701 Cr ₹1,812 Cr +23.0%
Operating Profit ₹416 Cr ₹468 Cr ₹488 Cr +12.3%
OPM % 30.09% 27.49% 26.96% -8.6%
NPM % 21.87% 15.30% 14.79% -30.0%
Other Income ₹57 Cr ₹50 Cr ₹68 Cr -13.0%
Depreciation ₹58 Cr ₹87 Cr ₹97 Cr +50.8%
Interest ₹24 Cr ₹79 Cr ₹100 Cr +236.0%
EBIT ₹359 Cr ₹381 Cr ₹392 Cr +6.1%
PBT ₹403 Cr ₹353 Cr ₹362 Cr -12.5%
Tax ₹73 Cr ₹43 Cr ₹45 Cr -40.7%
Net Profit ₹303 Cr ₹260 Cr ₹268 Cr -14.0%
EPS ₹13.63 ₹6.52 ₹6.71 -52.2%
Material Cost ₹210 Cr ₹170 Cr ₹192 Cr -19.3%
Employee Cost ₹177 Cr ₹144 Cr ₹161 Cr -18.4%
Extraordinary Items ₹11 Cr ₹-0 Cr ₹-0 Cr -102.8%

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 80808080 +0.0%
Reserves 1,5511,7862,0882,349 +12.5%
Borrowings 43267081,526 +115.5%
Other Liabilities 177204313330 +5.4%
Total Liabilities 1,8122,3973,1894,285 +34.4%
Fixed Assets 6126747731,534 +98.4%
CWIP 16292530116 -78.1%
Investments 8261,0621,2261,523 +24.2%
Other Assets 3583686601,113 +68.6%
Total Assets 1,8122,3973,1894,285 +34.4%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 271262294292 -0.7%
Cash from Investing Activity -238-569-627-956 -52.5%
Cash from Financing Activity -15289339662 +95.3%
Net Cash Flow 18-186-1 -116.7%
Free Cash Flow 150-58-12-63 -425.0%
CFO/OP 95%95%91%80% -12.1%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 39444960 +22.4%
Inventory Days ———44 —
Days Payable ———124 —
Cash Conversion Cycle 394449-21 -142.9%
Working Capital Days 123-23-35 -52.2%
ROCE % 23%17%16%13% -18.8%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 34.11%34.11%34.11%34.11%32.50% -4.7%
FIIs 15.54%15.03%14.33%14.57%14.74% +1.2%
DIIs 31.65%32.12%32.72%32.50%34.43% +5.9%
Public 18.68%18.74%18.85%18.82%18.33% -2.6%
No. of Shareholders 1,08,9551,04,8721,01,59993,33394,730 +1.5%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Krishna Institute of Medical Sciences Limited's revenue in Q1 FY27?
Krishna Institute of Medical Sciences Limited reported revenue of ₹484 crore for the quarter ended June 2026 (Q1 FY27), up 29.5% from ₹373 crore in the same quarter last year, and up 6.1% sequentially over the March 2026 quarter.
What was Krishna Institute of Medical Sciences Limited's net profit in Q1 FY27?
Net profit rose 13.1% year-on-year to ₹66 crore, from ₹59 crore. Earnings per share (EPS) came in at ₹1.66.
What is KIMS's market capitalisation and P/E ratio?
At the current price of ₹685.60, KIMS has a market capitalisation of ₹27,434 crore and a trailing P/E of about 102.4.
Who owns Krishna Institute of Medical Sciences Limited? (shareholding pattern)
As of Jun 2026, promoters held 32.50%, foreign institutional investors (FIIs) 14.74%, domestic institutional investors (DIIs) 34.43%, public shareholders 18.33% of Krishna Institute of Medical Sciences Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI